DelSiTech And Bayer Partner To Develop Innovative Drug Delivery Technology For Ophthalmology
On the picture:
DelSiTech Ltd, a Finnish drug delivery technology and drug development company, and Bayer have signed a Collaboration and Technology Licence Agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology. Read more.
DelSiTech Ltd., located in Turku, Finland, develops and commercializes its proprietary biodegradable silica based drug delivery technology. The Company collaborates with a number of pharma and biotech companies globally and works with its partners to turn their product ideas into novel drug products.
27 March 2017
ELISE: Spurring innovation eco-systems
20 March 2017
Copenhagen Bioscience Career Day 2